TMCI Dividend: Treace Medical Concepts Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

TMCI Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	213	209	187	141	94	57
Revenue Growth (YoY)	8%	12%	33%	50%	65%	46%
Cost of Revenue	42	41	35	27	17	12
Gross Profit	171	168	151	114	76	44
Selling, General & Admin	197	203	187	135	82	38
Research & Development	21	20	15	13	10	5
Operating Expenses	219	223	203	149	93	44
Other Non Operating Income (Expenses)	0	0	0	--	--	--
Pretax Income	-49	-55	-49	-42	-20	-3
Income Tax Expense	--	--	--	--	--	--
Net Income	-49	-55	-49	-42	-20	-4
Net Income Growth	-22%	12%	17%	110%	400%	0%
Shares Outstanding (Diluted)	63	62.11	60.85	55.3	48.4	50.5
Shares Change (YoY)	1%	2%	10%	14%	-4%	0%
EPS (Diluted)	-0.78	-0.89	-0.81	-0.77	-0.43	-0.09
EPS Growth	-23%	10%	6%	79%	378%	-10%
Free Cash Flow	-29	-48	-46	-45	-19	-5
Free Cash Flow Per Share	-0.46	-0.77	-0.75	-0.81	-0.39	-0.09
Gross Margin	80.28%	80.38%	80.74%	80.85%	80.85%	77.19%
Operating Margin	-22.06%	-26.31%	-27.27%	-24.11%	-17.02%	0%
Profit Margin	-23%	-26.31%	-26.2%	-29.78%	-21.27%	-7.01%
Free Cash Flow Margin	-13.61%	-22.96%	-24.59%	-31.91%	-20.21%	-8.77%
EBITDA	-38	-47	-46	-32	-16	1
EBITDA Margin	-17.84%	-22.48%	-24.59%	-22.69%	-17.02%	1.75%
D&A For EBITDA	9	8	5	2	0	1
EBIT	-47	-55	-51	-34	-16	0
EBIT Margin	-22.06%	-26.31%	-27.27%	-24.11%	-17.02%	0%
Effective Tax Rate	--	--	--	--	--	--